PWMG
AGIO icon

Prestige Wealth Management Group’s Agios Pharmaceuticals AGIO Stock Holding History

Prestige Wealth Management Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-34
Closed -$1K – 882
2020
Q1 		$1K Buy
+34
New +$1.57K ﹤0.01% 706

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Prestige Wealth Management Group's AGIO Position: Q2 2020 in Review

Prestige Wealth Management Group sold out of Agios Pharmaceuticals (AGIO) in Q2 2020, closing a stake of 34 shares — an estimated $1K sold.

Prestige Wealth Management Group first reported a position in AGIO in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 216 funds tracked by Wall St. Rank hold AGIO as of Q2 2020.

  • Prestige Wealth Management Group reported no remaining Agios Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Prestige Wealth Management Group sold 34 Agios Pharmaceuticals shares in Q2 2020, an estimated $1K.
  • Prestige Wealth Management Group first reported a position in Agios Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Prestige Wealth Management Group's Agios Pharmaceuticals position peaked at $1K in Q1 2020.
  • 216 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2020.

Based on Prestige Wealth Management Group's 13F filing for Q2 2020, filed 13 Aug 2020.